Summary
The DiFi human colorectal cancer cell line was recently established from a familial adenomatous polyposis patient with extracolonic features characteristic of the Gardner syndrome. These cells have now been propagated for 150 passages in standard culture media and vessels without feeder layers or collagen coatings. They retain features of colonic epithelial cells such as surface microvilli, secretory vesicles, and desmosomes. Cytosol of DiFi cells contains a high level (502 U/mg protein) of the mucin CA 19-9. In addition, DiFi cells produce carcinoembryonic antigen, and induce tumors in athymic mice. Cytoskeleton analysis of DiFi cells by fluorescence microscopy showed a pronounced disorganization of actin cable structure. The isozyme genetic signature of DiFi cells is unique (0.01 probability of finding the same genetic signature in a different cell line), differs from that of HeLa cells, and has expressional features seen in other colorectal cell lines. The DiFi cell karyotype is tetraploid, contains many marker chromosomes, and shows numerous episomal particles. Two copies of chromosome 18 were absent, and only a single normal chromosome 17 was found. This parallels detection of allelic losses from DiFi cell DNA at loci on chromosomes 17p and 18 using molecular (cDNA) probes. DiFi cells clearly express transcripts for the c-myc proto-oncogene, the c-myb proto-oncogene, and thep53 tumor suppressor gene. Transforming growth factor beta inhibits DiFi cell growth in soft agar and suppresses c-myc expression in these cells. The value of this cell line in the study of genetic alterations in colorectal cancer is discussed.
Similar content being viewed by others
References
Ahearn, M. J. Electron microscopy as an aid to the diagnosis and characterization of acute leukemia. In: Stass, S. A., ed. The acute leukemias: biologic, diagnostic, and therapeutic determinants. New York: Marcel Dekker, Inc.; 1987:87–130.
Ali, A. A.; Christensen, M. A.; Marcus, J. N., et al. The retinoblastoma protein in colorectal cancer. In: Rossini, F. P.; Winawer, S. J.; Lynch, H. T., eds. Recent progress in colorectal cancer: biology and management of high risk groups. Amsterdam: Elsevier Science Publishers B. V.; 1992:29–32.
Aviv, H.; Leder, P. Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose. Proc. Natl. Acad. Sci. USA 69:1408–1412; 1972.
Baker, F. L.; Spitzer, G.; Ajani, J. A., et al. Drug and radiation sensitivity measurements of successful primary monolayer culturing of human tumor cells using cell-adhesive matrix and supplemented medium. Cancer Res. 46:1263–1274; 1986.
Baker, S. J.; Fearon, E. R.; Nigro, J. M., et al. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science 244:217–221; 1989.
Baker, S. J.; Markowitz, S.; Fearon, E. R., et al. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249:912–915; 1990.
Boman, B. M.; Levin, B. Familial polyposis. Hosp. Pract. 21:155–170; 1986.
Boman, B. M. Biomolecular genetics of cancer. In: Lynch, H., ed. Genetic epidemiology of cancer. Boca Raton, FL: CRC Press, Inc.; 1988:343–349.
Boman, B. M.; Wildrick, D. M.; Alfaro, S. R. Chromosome 18 allele loss at the D18S6 locus in human colorectal carcinomas. Biochem. Biophys. Res. Commun. 155:463–469; 1988.
Bos, J. L.; Fearon, E. R.; Hamilton, S. L., et al. Prevalence ofras gene mutations in human colorectal cancer. Nature 327:293–297; 1987.
Brenner, S.; Pepper, D.; Berns, M., et al. Kinetochore structure, duplication, and distribution in mammalian cells: analysis by human autoantibodies from scleroderma patients. J. Cell Biol. 91:95–102; 1981.
Bulow, S. Familial polyposis coli. Dan. Med. Bull. 34:1–15; 1987.
Cailleau, R.; MacKay, B.; Young, R. K., et al. Tissue culture studies on pleural effusion from breast carcinoma patients. Cancer Res. 34:801–809; 1974.
Chen, T. R.; Microscopic demonstration of mycoplasma contamination in cell cultures and cell culture media. Procedure 75361, Tissue Culture Assoc. Manual 1:229–232; 1975.
Chirgwin, J. M.; Przybyla, A. E.; MacDonald, R. J., et al. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294; 1979.
Coffey, R. J., Jr.; Shipley, G. D.; Moses, H. M. Production of transforming growth factors by human colon cancer lines. Cancer Res. 46:1164–1169; 1986.
Coffey, R. J.; Bascom, C. C.; Sipes, N. J., et al. Selective inhibition of growth-related gene expression in murine keratinocytes by transforming growth factor beta. Mol. Cell. Biol. 8:3088–3093; 1988.
Del Villano, B. C.; Brennan, S.; Brock, P., et al. Radioimmunometric assay for a monoclonal antibody-defined tumor marker, CA 19-9. Clin. Chem. 29:549–552; 1983.
Delattre, O.; Law, D. J.; Remvikos, Y., et al. Multiple genetic alterations in distal and proximal colorectal cancer. Lancet 1989;353-356; 1989.
Dolf, G.; Meyn, R. E.; Curley, D., et al. Extrachromosomal amplification of the epidermal growth factor receptor gene in a human colon carcinoma cell line. Genes Chrom. Cancer 3:48–54; 1991.
Erisman, M. D.; Scott, J. K.; Astrin, S. M. Evidence that the familial adenomatous polyposis gene is involved in a subset of colon cancers with a complementable defect in c-myc regulation. Proc. Natl. Acad. Sci. USA 86:4264–4268; 1989.
Fearon, E. R.; Cho, K. R.; Nigro, J. M., et al. Identification of a chromosome 18q gene that is altered in colorectal cancers. Science 247:49–56; 1990.
Friedman, E.; Verderame, M.; Winawer, S., et al. Actin cytoskeletal organization loss in the benign-to-malignant tumor transition in cultured human colonic epithelial cells. Cancer Res. 44:3040–3050; 1984.
Friedman, E.; Verderame, M.; Lipkin, M., et al. Altered actin cytoskeletal pattern in two premalignant stages in human colon carcinoma development. Cancer Res. 45:3236–3242; 1985.
Gardner, E. J. Familial polyposis coli and Gardner syndrome—is there a difference? In: Ingall, J. R. F.; Mastromarino, A. J., eds. Prevention of hereditary large bowel cancer. New York: A. R. Liss, Inc.; 1983:39–60.
Giovanella, B. C.; Stehlin, J. S. Heterotransplantation of human malignant tumors in “nude” thymusless mice. I. Breeding and maintenance of “nude” mice. JNCI 51:615–619; 1973.
Gope, R.; Christensen, M. A.; Thorson, A., et al. Increased expression of the retinoblastoma gene in human colorectal carcinomas relative to normal colonic mucosa. JNCI 82:310–314; 1990.
Gross, M. E.; Zorbas, M. A.; Danels, Y. J., et al. Cellular growth response to epidermal growth factor in colon carcinoma cells with an amplified epidermal growth factor receptor derived from a familial adenomatous polyposis patient. Cancer Res. 51:1452–1459; 1991.
Hoosein, N. M.; McKnight, M. K.; Levine, A. E., et al. Differential sensitivity of subclasses of human colon carcinoma cell lines to the growth inhibitory effects of transforming growth factor-beta1. Exp. Cell Res. 181:442–453; 1989.
Johnson, G. D.; de C, Nogueria Aravjo, G. M. A simple method of reducing the fading of immunofluorescence during microscopy. J. Immunol. Methods 43:349–350; 1981.
Kinzler, K. W.; Nilbert, M. C.; Su, L.-K., et al. Identification of FAP locus genes from chromosome 5q21. Science 253:661–665; 1991.
Kinzler, K. W.; Nilbert, M. C.; Vogelstein, B., et al. Identification of a gene located at chromosome 5q21 that is mutated in colorectal cancers. Science 251:1366–1370; 1991.
Kopelovich, L.; Conlon, S.; Pollack, R. Defective organization of actin in cultured skin fibroblasts from patients with inherited adenocarcinoma. Proc. Natl. Acad. Sci. USA 74:3019–3022; 1977.
Lowry, O. H.; Rosebrough, N. J.; Farr, A. L., et al. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:265–275; 1951.
Lynch, H. T.; Boman, B. M.; Lanspa, S., et al. Heritage of colon polyps. In: Herrera, L., ed. Familial adenomatous polyposis. New York: A. R. Liss, Inc.; 1988:9–15.
Lynch, H. T.; Boman, B. M.; Fitzgibbons, R. J. Familial polyposis coli: genetics, surveillance, and treatment. Nebr. State Med. J. 73:329–334; 1988.
Magnani, J. L.; Steplewski, Z.; Koprowski, H., et al. Identification of the gastrointestinal and pancreatic cancer-associated antigen detected by monoclonal antibody 19-9 in the sera of patients as a mucin. Cancer Res. 43:5489–5492; 1983.
Monpezat, J. P.; Delattre, D.; Bernard, A., et al. Loss of alleles on chromosome 18 and on the short arm of chromosome 17 in polyploid colorectal carcinomas. Int. J. Cancer 41:404–408; 1988.
Mulder, K. M.; Levine, A. E.; Hernandez, X., et al. Modulation of c-myc by transforming growth factor-beta in human colon carcinoma cells. Biochem. Biophys. Res. Commun. 150:711–716; 1988.
Nakamura, Y.; Lathrop, M.; Leppert, M., et al. Localization of the genetic defect in familial adenomatous polyposis within a small region of chromsome 5. Am. J. Hum. Genet. 43:638–644; 1988.
Namba, M.; Miyamoto, K.; Hyodoh, F., et al. Establishment and characterization of a human colon carcinoma cell line (KMS-4) from a patient with hereditary adenomatosis of the colon and rectum. Int. J. Cancer 32:697–702; 1983.
Nishisho, I.; Nakamura, Y.; Miyoshi, Y., et al. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 253:665–669; 1991.
Paraskeva, C.; Buckle, B. G.; Sheer, D., et al. The isolation and characterization of colorectal epithelial cell lines at different stages in malignant transformation from familial polyposis coli patients. Int. J. Cancer 34:49–56; 1984.
Pathak, S. Chromosome banding techniques. J. Reprod. Med. 17:25–28; 1976.
Rutzky, L. P.; Siciliano, M. J. Various isozyme gene expression patterns among human colorectal adenocarcinoma cell lines and tissues. JNCI 68:81–90; 1982.
Schroy, P.; Rifkin, J.; Coffey, R. J., et al. Role of transforming growth factor beta 1 in induction of colon carcinoma differentiation by hexamethylene bisacetamide. Cancer Res. 50:261–265; 1990.
Siciliano, M. J.; Barker, P. E.; Cailleau, R. Mutually exclusive genetic signatures of human breast tumor cell lines with a common chromosomal marker. Cancer Res. 39:919–922; 1979.
Sugio, K.; Kurata, S.-I.; Sasaki, M., et al. Differential expression of c-myc gene and c-fos gene in premalignant and malignant tissues from patients with familial polyposis coli. Cancer Res. 48:4855–4861; 1988.
Suradet, L.; Gaide, A.-C.; Calmes, J.-M., et al. Responsiveness of three newly established human colorectal cancer cell lines to transforming growth factors beta1 and beta2. Cancer Res. 52:3705–3712; 1992.
Untawale, S.; Blick, M. Oncogene expression in adenocarcinomas of the colon and in colon tumor-derived cell lines. Anticancer Res. 8:1–8; 1988.
Vogelstein, B.; Fearon, E. R.; Hamilton, S. R., et al. Genetic alterations during colorectal-tumor development. N. Engl. J. Med. 319:525–532; 1988.
Whitehead, R. H.; Macrae, F. A.; St. John, D. J., et al. A colon cancer cell line (LIM 1215) derived from a patient with inherited nonpolyposis colorectal cancer. JNCI 74:759–765; 1985.
Widrick, D. M. Molecular genetic studies of colon cancer. Hematol. Oncol. Clin. North Am. 3:1–18; 1989.
Wildrick, D. M.; Boman, B. M. Chromsome 5 allele loss at the glucocorticoid receptor locus in human colorectal carcinomas. Biochem. Biophys. Res. Commun. 150:591–598; 1988.
Wildrick, D. M.; Alfaro, S. R.; Gope, R., et al. A study of chromosome 6 allele loss in human colorectal carcinomas. Anticancer Res. 12:1717–1720; 1992.
Wong-Staal, F.; Reitz, M. S.; Gallo, R. C. Retrovirus sequences in a leukemic gibbon and its contact: evidence for partial provirus in the nonleukemic gibbon. Proc. Natl. Acad. Sci. USA 76:2032–2036; 1979.
Yan, Z.; Hsu, S.; Winawer, S., et al. Transforming growth factor beta1 (TGF-beta1) inhibits retinoblastoma gene expression but not pRB phosphorylation in TGF-Beta-1-growth stimulated colon carcinoma cells. Oncogene. 7:801–805; 1992.
Young, R. K.; Cailleau, R. M.; MacKay, B., et al. Establishment of epithelial cell line MDA-MB 157 from metastatic pleural effusion of human breast carcinoma. In Vitro 9:239–245; 1974.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Olive, M., Untawale, S., Coffey, R.J. et al. Characterization of the DiFi Rectal carcinoma cell line derived from a familial adenomatous polyposis patient. In Vitro Cell Dev Biol - Animal 29, 239–248 (1993). https://doi.org/10.1007/BF02634191
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02634191